The U.S. Medicine Chest: Implications of Increased Reliance on China

Public concern about the safety of medicines has been heightened with the recent recall of more than half of all valsartan products on the market in the United States after the Food and Drug Administration identified a probable cancer-causing chemical in the active pharmaceutical ingredient, which was made in China. This commentary discusses the increased reliance of the United States on China as a supplier of generic drugs, active pharmaceutical ingredients, and the chemical building blocks and raw materials to make them.

https://ift.tt/2Gkaf0m